ASX - By Stock
|
PAA |
Re:
2022 Moving Toward 2023
|
|
kpax
|
92 |
20K |
22 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
92
|
20K
|
22
|
|
ASX - By Stock
|
PAA |
Re:
2022 Moving Toward 2023
|
|
kpax
|
92 |
20K |
21 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
92
|
20K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
2022 Moving Toward 2023
|
|
kpax
|
92 |
20K |
16 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
92
|
20K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
2022 Moving Toward 2023
|
|
kpax
|
92 |
20K |
19 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
92
|
20K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
2022 Moving Toward 2023
|
|
kpax
|
92 |
20K |
18 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
92
|
20K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
2022 Moving Toward 2023
|
|
kpax
|
92 |
20K |
13 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
92
|
20K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
2022 Moving Toward 2023
|
|
kpax
|
92 |
20K |
11 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
92
|
20K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
kpax
|
41 |
9.6K |
8 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
41
|
9.6K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
kpax
|
41 |
9.6K |
15 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
41
|
9.6K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
kpax
|
41 |
9.6K |
20 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
41
|
9.6K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
kpax
|
41 |
9.6K |
21 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
41
|
9.6K
|
21
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
2 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
16K
|
2.7M
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
AGM Questions 2022
|
|
kpax
|
78 |
17K |
9 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
78
|
17K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: First Patient Dosed in MND Phase 1/2 Trial
|
|
kpax
|
171 |
44K |
24 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
171
|
44K
|
24
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
4 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
16K
|
2.7M
|
4
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
4 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
16K
|
2.7M
|
4
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
5 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
16K
|
2.7M
|
5
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
8 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
16K
|
2.7M
|
8
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
9 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
16K
|
2.7M
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
28 |
26/09/22 |
26/09/22 |
ASX - By Stock
|
1.4K
|
377K
|
28
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
11 |
22/09/22 |
22/09/22 |
ASX - By Stock
|
16K
|
2.7M
|
11
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
5 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
16K
|
2.7M
|
5
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
4 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
16K
|
2.7M
|
4
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
5 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
16K
|
2.7M
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on PharmAust Canine Cancer Trials
|
|
kpax
|
216 |
48K |
17 |
30/08/22 |
30/08/22 |
ASX - By Stock
|
216
|
48K
|
17
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
7 |
29/08/22 |
29/08/22 |
ASX - By Stock
|
16K
|
2.7M
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Where are you PAA ????
|
|
kpax
|
33 |
7.3K |
16 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
33
|
7.3K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Update on PharmAust Canine Cancer Trials
|
|
kpax
|
216 |
48K |
33 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
216
|
48K
|
33
|
|
ASX - By Stock
|
PAA |
Re:
Latest JP Equity Research Report - July 2022
|
|
kpax
|
36 |
8.9K |
26 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
36
|
8.9K
|
26
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C and Quarterly Update
|
|
kpax
|
44 |
10K |
26 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
44
|
10K
|
26
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
5 |
05/07/22 |
05/07/22 |
ASX - By Stock
|
16K
|
2.7M
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notification of cessation of securities - PAA
|
|
kpax
|
93 |
23K |
19 |
03/07/22 |
03/07/22 |
ASX - By Stock
|
93
|
23K
|
19
|
|
ASX - By Stock
|
CVN |
Re:
Ann: Pavo Resource Estimate
|
|
kpax
|
16 |
13K |
0 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
16
|
13K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
MND Phase 1/2/3 Trial review what to expect. The Chemistry !
|
|
kpax
|
14 |
3.8K |
20 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
14
|
3.8K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
MND Phase 1/2/3 Trial review what to expect. The Chemistry !
|
|
kpax
|
14 |
3.8K |
9 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
14
|
3.8K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
MND Phase 1/2/3 Trial review what to expect. The Chemistry !
|
|
kpax
|
14 |
3.8K |
18 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
14
|
3.8K
|
18
|
|
ASX - By Stock
|
PAA |
MND Phase 1/2/3 Trial review what to expect. The Chemistry !
|
|
kpax
|
14 |
3.8K |
21 |
07/06/22 |
07/06/22 |
ASX - By Stock
|
14
|
3.8K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Seventy Reason to Buy PAA
|
|
kpax
|
273 |
68K |
12 |
23/05/22 |
23/05/22 |
ASX - By Stock
|
273
|
68K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Expands Lymphoma Canine Trial to the USA
|
|
kpax
|
65 |
15K |
21 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
65
|
15K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Expands Lymphoma Canine Trial to the USA
|
|
kpax
|
65 |
15K |
21 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
65
|
15K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Seventy Reason to Buy PAA
|
|
kpax
|
273 |
68K |
10 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
273
|
68K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Seventy Reason to Buy PAA
|
|
kpax
|
273 |
68K |
13 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
273
|
68K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Phase 3 Canines Lymphoma B Trial ( what to expect)
|
|
kpax
|
98 |
21K |
9 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
98
|
21K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Phase 3 Canines Lymphoma B Trial ( what to expect)
|
|
kpax
|
98 |
21K |
13 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
98
|
21K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Phase 3 Canines Lymphoma B Trial ( what to expect)
|
|
kpax
|
98 |
21K |
19 |
10/04/22 |
10/04/22 |
ASX - By Stock
|
98
|
21K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Interesting Budget Item on Recycling
|
|
kpax
|
25 |
4.4K |
22 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
25
|
4.4K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
|
|
kpax
|
1.4K |
377K |
13 |
29/03/22 |
29/03/22 |
ASX - By Stock
|
1.4K
|
377K
|
13
|
|
ASX - By Stock
|
BDX |
Re:
Ann: Shareholder Newsletter
|
|
kpax
|
4 |
2.5K |
2 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
4
|
2.5K
|
2
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
6 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
16K
|
2.7M
|
6
|
|
ASX - By Stock
|
XJO |
Re:
XJO - Bear Posts only (Factors which might cause the markets to fall)
|
|
kpax
|
16K |
2.7M |
5 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
16K
|
2.7M
|
5
|
|